Yann Lécluse
Centre National de la Recherche Scientifique(FR)Inserm(FR)Université Paris-Saclay(FR)Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research, Cancer Genomics and Diagnostics, Chronic Myeloid Leukemia Treatments, CAR-T cell therapy research
Most-Cited Works
- → Mutation in TET2 in Myeloid Cancers(2009)1,725 cited
- → A novel dendritic cell subset involved in tumor immunosurveillance(2006)396 cited
- → The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera(2007)186 cited
- → The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis(2009)176 cited
- → Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera(2004)165 cited
- → Expression of CD41 on hematopoietic progenitors derived from embryonic hematopoietic cells(2002)153 cited